Finance

Beta
Lists
GSS:ASX
Genetic Signatures Ltd
A$0.078
+11.43%
(+0.0080) 1D
Jun 5, 4:10:03 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for GSS...
Open
A$0.07
High
A$0.08
Low
A$0.07
Mkt. cap
16.96M
Avg. vol.
642.38K
Volume
417.71K
52-wk high
A$0.46
52-wk low
A$0.07
EPS
-A$0.05
Shares outstanding
227.14M
Open
A$0.07
High
A$0.08
Low
A$0.07
Mkt. cap
16.96M
Avg. vol.
642.38K
Volume
417.71K
52-wk high
A$0.46
52-wk low
A$0.07
EPS
-A$0.05
Shares outstanding
227.14M
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to GSS in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for GSS in the last 3 months.
Highest
Current A$0.08
A$0.10 (+28.21%)
Average
A$0.10 (+28.21%)
Lowest
A$0.10 (+28.21%)
News stories
From sources across the web
About Genetic Signatures Ltd
CEOAllison Rossiter
Employees-
Founded2001
Headquarters-
SectorHealth care
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
5.63M
5.63M
4.34M
4.34M
Cost of goods sold
2.31M
2.31M
2.60M
2.60M
Cost of revenue
2.31M
2.31M
2.60M
2.60M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.94M
4.94M
5.18M
5.18M
Operating expense
5.99M
5.99M
5.17M
5.17M
Total operating expenses
8.30M
8.30M
7.77M
7.77M
Operating income
-2.67M
-2.67M
-3.43M
-3.43M
Other non operating income
-22.50K
-22.50K
-
-
EBT including unusual items
-2.45M
-2.45M
-3.18M
-3.18M
EBT excluding unusual items
-2.35M
-2.35M
-3.18M
-3.18M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
471.00K
471.00K
-535.50K
-535.50K
Net income
-2.45M
-2.45M
-3.18M
-3.18M
Net profit margin
-43.58%
-43.58%
-73.32%
-73.32%
Earnings per share
-
-
-
-
Interest and investment income
365.00K
365.00K
260.00K
260.00K
Interest expense
-23.00K
-23.00K
-14.00K
-14.00K
Net interest expenses
342.00K
342.00K
246.00K
246.00K
Depreciation and amortization charges
582.00K
582.00K
533.50K
533.50K
EBITDA
-2.20M
-2.20M
-3.01M
-3.01M
Gain or loss from assets sale
-31.50K
-31.50K
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more